Next-Generation Nutraceuticals is a new report published by Business Insights that provides analysis of how the food and pharmaceutical industries are becoming more aligned in their approach to consumer health. This report assesses the changing regulatory landscape in addition to how the strategies of leading ingredients, food, drinks and pharmaceutical companies are evolving in the new consumer health marketplace.

Consumers are taking a more proactive approach to managing their health and the prevention of diet-related diseases, such as obesity, diabetes, cardiovascular and bone and joint diseases. Many of these diseases are at epidemic levels, and this combined with increasing patient power makes the prevention of these lifestyle diseases attractive markets for both the food and pharmaceutical industries to exploit.
 
Understand how food and drinks manufacturers are applying genomic and proteomic technologies and how the convergence of the ‘food and drinks’ and ‘pharma’ markets will impact competitive dynamics.

 
Report price and information
Single user eCopy: £1495/€2160/$2875
 
See order form for details.
 

This report will enable you to:

• Understand how nutrigenomics will revolutionize the functional food and drinks market through enabling a more personalized approach to the management of diet and health, mirroring pharmacogenomic and personalized medicine developments in the pharmaceutical industry.
   
• Predict future food and pharma product developments using the report's critical evaluation of recent partnering activity between leading food and drinks companies and innovative biotechnology platform developers.
   
• Assess changing cross-market dynamics using this report’s analysis of convergence between companies including Chr. Hansen and BASF and the pharmaceutical industry and the innovative functional ingredients that this produces.
   
• Identify the opportunities and threats resulting from regulatory changes regarding health claims on food and drinks in Europe, the US and Japan , and the prospect of a closer alignment with pharmaceutical regulation in the development of the next generation of functional food and drink products.

Some key questions answered by this report:

• How will regulatory changes affect the future of functional foods and drinks globally?
• Which companies are the leading innovators in nutrigenomics and with whom are they partnering?
• How are functional food and drinks evolving to have qualities associated with pharma products?
• How are the food and pharma industries tackling the prevention of lifestyle related health problems including obesity, diabetes and cardiovascular disease?